ストックスクリーナーアプリを入手
1.72
6.17%
0.10
プレマーケット:
1.75
0.03
+1.74%
前日終値:
$1.62
開ける：
$1.63
24時間の取引高:
1.04M
Relative Volume:
0.36
時価総額：
$103.75M
収益：
-
当期純損益:
$-33.85M
株価収益率:
-3.0507
EPS:
-0.5638
ネットキャッシュフロー:
$-33.35M
1週間 パフォーマンス:
+9.55%
1か月 パフォーマンス:
+3.61%
6か月 パフォーマンス:
-65.11%
1年 パフォーマンス:
-36.30%
1日の値動き範囲:
$1.59
$1.73
1週間の範囲:
$1.47
$1.73
52週間の値動き範囲:
$1.07
$6.175
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
名前
Aldeyra Therapeutics Inc
セクター
電話
781-761-4904
住所
131 HARTWELL AVENUE, LEXINGTON, MA
Compare ALDX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
1.72 | 97.72M | 0 | -33.85M | -33.35M | -0.5638 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-04-03 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-04-02 | 再開されました | H.C. Wainwright | Buy |
| 2022-04-27 | 再開されました | H.C. Wainwright | Buy |
| 2021-02-08 | 開始されました | H.C. Wainwright | Buy |
| 2020-12-16 | 開始されました | Berenberg | Buy |
| 2020-10-30 | 開始されました | Jefferies | Buy |
| 2020-10-16 | 開始されました | BTIG Research | Buy |
| 2020-09-22 | 開始されました | Alliance Global Partners | Buy |
| 2020-05-12 | 開始されました | Oppenheimer | Outperform |
| 2018-12-04 | 開始されました | Citigroup | Buy |
| 2018-09-26 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-09-13 | 開始されました | Janney | Buy |
| 2018-01-26 | 開始されました | Seaport Global Securities | Buy |
| 2016-09-26 | 開始されました | H.C. Wainwright | Buy |
| 2016-07-01 | 開始されました | Stifel | Buy |
| 2015-07-01 | 開始されました | Canaccord Genuity | Buy |
| 2015-03-25 | 開始されました | Chardan Capital Markets | Buy |
| 2015-03-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2014-11-18 | 開始されました | H.C. Wainwright | Buy |
| 2014-06-19 | 開始されました | Aegis Capital | Buy |
すべてを表示
Aldeyra Therapeutics Inc (ALDX) 最新ニュース
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX - ChartMill
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - ChartMill
ROSEN, A TOP RANKED LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmALDX - TMX Newsfile
Biotech Downgraded to Neutral After Second FDA CRL for Reproxalap in Dry Eye Disease - Streetwise Reports
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ALDX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - ChartMill
ALDX UPCOMING DEADLINE : The Gross Law Firm Alerts Aldeyra Therapeutics, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
Pleasing Signs As A Number Of Insiders Buy Aldeyra Therapeutics Stock - Yahoo Finance
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmALDX - TMX Newsfile
ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel ... - Black Hills Pioneer
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The FirmALDX - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - mydailyrecord.com
ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
Aldeyra Updates Reproxalap Outlook and Extends Cash Runway - TipRanks
Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors with Large Losses to Contact the Firm Regarding Their Rights Before May 29th - GlobeNewswire
MSN Money - MSN
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
AbbVie option and FDA feedback reshape Aldeyra (Nasdaq: ALDX) drug plans - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Press releases provided by CNW - Techaeris
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming DeadlinesALDX - ChartMill
REMINDER: Aldeyra Therapeutics, Inc. Investors With Significant Losses Must Act By May 29, 2026 - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ALDX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds - GuruFocus
ALDX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - Morningstar
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Executives Allegedly Certified Misleading Filings: SueWallSt – Company AnnouncementFT.com - Financial Times
ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsu - GuruFocus
ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Does Aldeyra Therapeutics (ALDX) have the potential to rally 79.28% as Wall Street analysts expect? - MSN
Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Aldeyra Therapeutics, Inc. - The Joplin Globe
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Aldeyra Therap - The National Law Review
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ALDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - marketscreener.com
ALDX DEADLINE: The Gross Law Firm Reminds Aldeyra Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline - ChartMill
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmALDX - TMX Newsfile
Aldeyra Therapeutics | DEF 14A: Definitive information statements - Moomoo
[ARS] Aldeyra Therapeutics, Inc. SEC Filing - Stock Titan
CEO pay, board election and auditor up for Aldeyra (NASDAQ: ALDX) 2026 vote - Stock Titan
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aldeyra - GlobeNewswire
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Portnoy Law Firm Announces Class Action on Behalf of Aldeyra Therapeutics, Inc. Investors - GlobeNewswire
ALDX Technical Analysis | Trend, Signals & Chart Patterns | ALDEYRA THERAPEUTICS INC (NASDAQ:ALDX) - ChartMill
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmALDX - TMX Newsfile
ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ALDX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - marketscreener.com
Aldeyra receives FDA rejection for dry eye treatment reproxalap - MSN
Aldeyra Therapeutics Inc (ALDX) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):